VIVITROL Provider Information - Florida Become a member
Coming Soon

Where It’s At: Levels of Care for Induction of Medication Assisted Treatment



Location:

Orlando


Date and Time:

Tuesday, January 30, 2018 - 09:00 AM - 04:00 PM


Description:

Evidence-based Medication in Addiction Treatment  must start somewhere – and it turns out that can be anywhere. The patient’s needs must be thoroughly understood and the treatment services must be prepared to meet all acute needs. The ASAM Criteria assessment dimensions and service specifications provide a valuable framework for structuring successful initiation of MAT and longitudinal recovery.

Learning Objectives:

As a result of participating in the workshop, participants will be able to:

  1. Identify and utilize the six dimensions of assessment for effective patient induction into Medication Assisted Treatment (MAT)
     
  2. Structure clinical services to meet patient MAT induction needs according to the ASAM criteria
     
  3. Implement the placement, prescribing, dosing, dispensing and monitoring necessary for effective MAT induction in opioid use disorder.

Who should attend?

This training is relevant to a variety of health and human service professionals and paraprofessionals, such as health care professionals (physicians, pharmacists, nurses, emergency medical personnel, etc.), law enforcement, mental health and addiction professionals, behavioral health technicians, recovery support personnel, and community members at risk of experiencing or witnessing an opioid overdose.


Presented by:

Dr. Gastfriend is Senior Research Scientist at the Treatment Research Institute (TRI). An addiction psychiatrist, he directed addiction research at Massachusetts General Hospital and was an investigator in the NIDA Cocaine Collaborative Study, the NIAAA COMBINE Study and the NIDA Clinical Trials Network. As Vice President at Alkermes, Inc., Dr. Gastfriend conducted biological, clinical, health economics and policy research on behalf of the company’s efforts in the field of addiction treatment. For 25 years, Dr. Gastfriend served on the faculty of Harvard Medical School, notably as the Director of the Addiction Research Program at Massachusetts General Hospital and founder of the MGH/McLean Hospital Fellowship in Addiction Psychiatry. He is considered the world’s leading expert on two important treatment tools from both the biological and psychosocial realms: the opioid blocker Vivitrol, and the American Society of Addiction Medicine (ASAM) Criteria Software.

Dr. Gastfriend’s ASAM Criteria research contributed to their endorsement by most U.S. states, the VA and DOD. His 150 scientific publications include The ASAM Criteria and Addiction Treatment Matching. His CONTINUUM – The ASAM Criteria Decision Engine™ and ASAM’s CO-Triage™ are being used across Los Angeles County, the California state prison system, Massachusetts, and elsewhere. Dr. Gastfriend’s newest project is DynamiCare Health™, a technology platform for scaling up Contingency Management treatment and machine learning predictive analytics for routine care. He has consulted to the governments of Belgium, China, Iceland, Israel, Norway, Russia and the U.S. He received his B.A. at Haverford College in Philadelphia, and his M.D. from Jefferson Medical College in Philadelphia.


Where:

Hilton Garden Inn Sea World
6850 Westwood Boulevard
Orlando, FL 32821
(407) 354-1500

www.hiltongardeninnseaworld.com

 


CEUs:

5.5 Continuing Education Units/Contact Hours are provided for this event


Florida Certification Board Recognized Education Provider
Florida Board of Social Work, Marriage and Family Therapy and Mental Health Counseling Provider #50-676, Exp. Date 3/31/2019
Florida Board of Nursing Provider #50-676, Exp. Date 10/31/2018


dcf


Workshop Registration is Full

Please email (mweeks@fadaa.org) to be added to the waiting list.



container bottom